German HTA Body Slams Lack Of 'Real Innovation'
Executive SummaryToo many new drugs have the same mechanism of action, says Germany’s health technology appraisal institute, IQWiG.
You may also be interested in...
Pharmaceutical companies should be obliged to carry out comparative trials, according to analysis from Germany’s Institute For Quality and Efficiency in Healthcare, IQWiG.
Performance-based managed entry agreements need to be made more effective, but this can only happen if countries relax their stance on confidentiality and share information on MEAs amongst themselves, says a working paper from the OECD.